Denied

No. 20-1293

AbbVie Inc., et al. v. Federal Trade Commission

from the United States Court of Appeals for the Third Circuit

See other cases from the Third Circuit.

Docket Entries

Petition DENIED. Justice Alito took no part in the consideration or decision of this petition.

Reply of petitioners AbbVie Inc., Abbott Laboratories, Unimed Pharmaceuticals LLC, and Besins Healthcare, Inc. filed. (Distributed)

DISTRIBUTED for Conference of 6/17/2021.

Letter waiving the 14-day waiting period for the filing of a reply pursuant to Rule 15.5 filed.

Brief of respondent United States in opposition filed.

Brief amici curiae of Pharmaceutical Research and Manufacturers of America and Biotechnology Innovation Organization filed.

Brief amici curiae of Law Professors filed.

Brief amicus curiae of Chamber of Commerce of the United States of America filed.

Motion to extend the time to file a response is granted and the time is extended to and including May 19, 2021.

Motion to extend the time to file a response from April 19, 2021 to May 19, 2021, submitted to The Clerk.

Petition for a writ of certiorari filed. (Response due April 19, 2021)

Parties

AbbVie Inc., Abbott Laboratories, Unimed Pharmaceuticals LLC, and Besins Healthcare, Inc., Petitioner, represented by Seth P. Waxman

United States, Respondent, represented by Elizabeth B. Prelogar

Amici Curiae

Chamber of Commerce of the United States of America, Amicus Curiae, represented by Ilana Hope Eisenstein

Law Professors, Amicus Curiae, represented by J. Mark Gidley

Pharmaceutical Research and Manufacturers of America and Biotechnology Innovation Organization, Amicus Curiae, represented by Mark W. Mosier

 
Last updated: July 29, 2021